Improving Outcomes for Patients With HR+/HER2- Advanced Breast Cancer

Join two nationally renowned breast oncology experts in this dynamic webinar focused on improving outcomes for patients with HR+/HER2- advanced breast cancer, with a special emphasis on targeting the PI3K/AKT/PTEN pathway. This session will explore the latest clinical data on PI3K and AKT inhibitors, and provide practical strategies for applying this knowledge in real-world patient care. Through case studies, live polling, and a Q&A session, the faculty will guide you through treatment options, patient selection, and best practices for managing adverse events associated with targeted therapies.